| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
AKT inhibitor Hu7691 induces differentiation of neuroblastoma cells
|
Bing, Shaowei
|
|
|
13 |
4 |
p. 1522-1536
|
article
|
| 2 |
A novel biological sources consistency evaluation method reveals high level of biodiversity within wild natural medicine: A case study of Amynthas earthworms as “Guang Dilong”
|
Xing, Zhimei
|
|
|
13 |
4 |
p. 1755-1770
|
article
|
| 3 |
Berberine ameliorates chronic kidney disease through inhibiting the production of gut-derived uremic toxins in the gut microbiota
|
Pan, Libin
|
|
|
13 |
4 |
p. 1537-1553
|
article
|
| 4 |
Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives
|
Ye, Zi-Han
|
|
|
13 |
4 |
p. 1467-1487
|
article
|
| 5 |
Cholinergic dysfunction-induced insufficient activation of alpha7 nicotinic acetylcholine receptor drives the development of rheumatoid arthritis through promoting protein citrullination via the SP3/PAD4 pathway
|
Lv, Changjun
|
|
|
13 |
4 |
p. 1600-1615
|
article
|
| 6 |
Commentary: Can FXR serve as a potential target for COVID-19 prevention?
|
Pang, Juan
|
|
|
13 |
4 |
p. 1786-1788
|
article
|
| 7 |
Cover Story
|
|
|
|
13 |
4 |
p. xi
|
article
|
| 8 |
Discovery of a first-in-class ANXA3 degrader for the treatment of triple-negative breast cancer
|
Liang, Yongxi
|
|
|
13 |
4 |
p. 1686-1698
|
article
|
| 9 |
Doxorubicin-conjugated siRNA lipid nanoparticles for combination cancer therapy
|
Butowska, Kamila
|
|
|
13 |
4 |
p. 1429-1437
|
article
|
| 10 |
Editorial of Special Column on RNA Therapeutics and Drug Delivery Technologies for Medical Applications
|
Tao, Wei
|
|
|
13 |
4 |
p. 1346-1347
|
article
|
| 11 |
Editor Profile: Guest Editor of Special Column on RNA Therapeutics and Drug Delivery Technologies for Medical Applications
|
|
|
|
13 |
4 |
p. 1345
|
article
|
| 12 |
Endothelial METRNL determines circulating METRNL level and maintains endothelial function against atherosclerosis
|
Zheng, Sili
|
|
|
13 |
4 |
p. 1568-1587
|
article
|
| 13 |
mRNA delivery in cancer immunotherapy
|
Zhong, Yichen
|
|
|
13 |
4 |
p. 1348-1357
|
article
|
| 14 |
On-demand integrated nano-engager converting cold tumors to hot via increased DNA damage and dual immune checkpoint inhibition
|
Liu, Xiaoqing
|
|
|
13 |
4 |
p. 1740-1754
|
article
|
| 15 |
Pancreatic melatonin enhances anti-tumor immunity in pancreatic adenocarcinoma through regulating tumor-associated neutrophils infiltration and NETosis
|
Chan, Yau-tuen
|
|
|
13 |
4 |
p. 1554-1567
|
article
|
| 16 |
Progress in non-viral localized delivery of siRNA therapeutics for pulmonary diseases
|
Gao, Jingjing
|
|
|
13 |
4 |
p. 1400-1428
|
article
|
| 17 |
Recent advances in diverse nanosystems for nitric oxide delivery in cancer therapy
|
Gao, Dan
|
|
|
13 |
4 |
p. 1498-1521
|
article
|
| 18 |
Recent progress of aptamer‒drug conjugates in cancer therapy
|
He, Jiaxuan
|
|
|
13 |
4 |
p. 1358-1370
|
article
|
| 19 |
Self-assembled multifunctional nanotheranostics against circulating tumor clusters in metastatic breast cancer
|
Dhandapani, Ramya
|
|
|
13 |
4 |
p. 1711-1725
|
article
|
| 20 |
Spatiotemporally resolved metabolomics and isotope tracing reveal CNS drug targets
|
Jin, Bo
|
|
|
13 |
4 |
p. 1699-1710
|
article
|
| 21 |
Structural diversification of bioactive bibenzyls through modular co-culture leading to the discovery of a novel neuroprotective agent
|
Liu, Yuyu
|
|
|
13 |
4 |
p. 1771-1785
|
article
|
| 22 |
Structural repurposing of SGLT2 inhibitor empagliflozin for strengthening anti-heart failure activity with lower glycosuria
|
Xu, Yixiang
|
|
|
13 |
4 |
p. 1671-1685
|
article
|
| 23 |
α/Sulfono-γ-AA peptide hybrids agonist of GLP-1R with prolonged action both in vitro and in vivo
|
Shi, Yan
|
|
|
13 |
4 |
p. 1648-1659
|
article
|
| 24 |
Table of Contents
|
|
|
|
13 |
4 |
p. iii-xi
|
article
|
| 25 |
Targeted delivery of RNAi to cancer cells using RNA-ligand displaying exosome
|
Uddin, Nasir
|
|
|
13 |
4 |
p. 1383-1399
|
article
|
| 26 |
The E3 ubiquitin ligase NEDD4-1 protects against acetaminophen-induced liver injury by targeting VDAC1 for degradation
|
Zhu, Yiwei
|
|
|
13 |
4 |
p. 1616-1630
|
article
|
| 27 |
The impact of lipids on the cancer–immunity cycle and strategies for modulating lipid metabolism to improve cancer immunotherapy
|
Zheng, Mingming
|
|
|
13 |
4 |
p. 1488-1497
|
article
|
| 28 |
The regulatory mechanisms and inhibitors of isocitrate dehydrogenase 1 in cancer
|
Liu, Yang
|
|
|
13 |
4 |
p. 1438-1466
|
article
|
| 29 |
The tumor therapeutic potential of long non-coding RNA delivery and targeting
|
Han, Shuo
|
|
|
13 |
4 |
p. 1371-1382
|
article
|
| 30 |
TRIB3 promotes pulmonary fibrosis through inhibiting SLUG degradation by physically interacting with MDM2
|
Lv, Xiaoxi
|
|
|
13 |
4 |
p. 1631-1647
|
article
|
| 31 |
Ultrasmall, elementary and highly translational nanoparticle X-ray contrast media from amphiphilic iodinated statistical copolymers
|
Su, Lu
|
|
|
13 |
4 |
p. 1660-1670
|
article
|
| 32 |
Ultrasmall iron-quercetin metal natural product nanocomplex with antioxidant and macrophage regulation in rheumatoid arthritis
|
Han, Zhihui
|
|
|
13 |
4 |
p. 1726-1739
|
article
|
| 33 |
YAP regulates the liver size during the fasting-refeeding transition in mice
|
Li, Xuan
|
|
|
13 |
4 |
p. 1588-1599
|
article
|
Journal description